COEP
Coeptis Therapeutics·NASDAQ
--
--(--)
--
--(--)
COEP fundamentals
Coeptis Therapeutics (COEP) expects to report earnings on Aug 16, 2024, with estimated revenue of -- (YoY 0.00%), and EPS at -1.8 (YoY +35.71%).
Revenue estimate / YoY
--
0.00%
EPS estimate / YoY
-1.8
+35.71%
Report date
Aug 16, 2024
EPS
Revenue
Revenue & Expenses
COEP has released its 2025 Q3 earnings report, with revenue of 237.44K, reflecting a YoY change of NaN%, and net profit of -2.90M, showing a YoY change of -58.50%. The Sankey diagram below clearly presents COEP's revenue sources and cost distribution.
Key Indicators
Coeptis Therapeutics (COEP) key financial stats and ratios, covering profitability, financial health, and leverage.
Coeptis Therapeutics (COEP)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Coeptis Therapeutics (COEP)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Coeptis Therapeutics (COEP)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Coeptis Therapeutics (COEP) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Coeptis Therapeutics (COEP) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Coeptis Therapeutics’s earnings call?What were the key takeaways from Coeptis Therapeutics's earnings call?What is Coeptis Therapeutics's gross profit margin?What factors drove the changes in Coeptis Therapeutics's revenue and profit?What guidance did Coeptis Therapeutics's management provide for the next earnings period?What is the revenue and EPS growth rate for Coeptis Therapeutics year over year?What is Coeptis Therapeutics's latest dividend and current dividend yield?What is the market's earnings forecast for Coeptis Therapeutics next quarter?
